COMMUNIQUÉS West-GlobeNewswire

Range Impact Announces Application to Uplist to the OTCQB Venture Market

20/09/2024 - 15:15

CLEVELAND, OHIO, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact” or the “Company”), a public company dedicated to improving the health and wellness of people and the planet through a [...]

Koelis Announces Partnership and Initial Experience with DeepHealth for AI-powered Prostate MRI Interpretation and Guidance in Fusion Biopsy

20/09/2024 - 15:07

GRENOBLE, France and PRINCETON, N.J., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com ), a global leader and innovator in prostate care, announced today the partnership and [...]

Supernus Pharmaceuticals to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit

19/09/2024 - 22:30

ROCKVILLE, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous [...]

ADR Ratio Change

19/09/2024 - 22:30

September 19, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a [...]

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

19/09/2024 - 22:15

WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization [...]

GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update

19/09/2024 - 22:10

Cash and cash equivalents totaled €61.6 million as of June 30, 2024, excluding the €48.7 million milestone invoiced in June 2024 (received in August 2024) upon first sale of Ipsen’s Iqirvo® (elafibranor) in the U.S. for [...]

GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société

19/09/2024 - 22:10

Trésorerie et équivalents de trésorerie s’éle vant à 61,6 m illio ns d’euros au 30 juin 2024 n’incluant pas le paiement d’étape de 48,7 millions d’euros facturé en juin 2024 (reçu en août 2024) lors de la première vente [...]

Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update

19/09/2024 - 22:05

FDA lifts partial clinical holds on ersodetug for the treatment of congenital HI; Phase 3 sunRIZE study to proceed in the U.S. Phase 3 study for ersodetug for the treatment of tumor HI expected to commence in the first [...]

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

19/09/2024 - 22:03

SAN FRANCISCO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative [...]

Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45

19/09/2024 - 22:01

TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relationship which was used to identify doses for the Phase 2 clinical trial Results to be presented at the American Heart [...]

Altamira Therapeutics Announces Closing of up to $12.0 Million Public Offering

19/09/2024 - 22:01

Hamilton, Bermuda, Sept. 19, 2024 (GLOBE NEWSWIRE) -- $4 million upfront with up to an additional $8 million of aggregate gross proceeds upon the exercise in full for cash of milestone-linked warrants Altamira [...]

Cytokinetics Announces Upcoming Presentations at the HCMS Scientific Sessions and the HFSA Annual Scientific Meeting

19/09/2024 - 22:00

Analyses of Effects of Aficamten on Key Clinical Outcomes from SEQUOIA-HCM to be Featured in Late Breaking Clinical Trial Presentation at HFSA SOUTH SAN FRANCISCO, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Cytokinetics [...]

Rejuveron Life Sciences AG prend le nom de Centenara Labs AG et fait le point sur les dernières données cliniques

19/09/2024 - 21:47

Les actionnaires approuvent le changement de dénomination sociale sous la marque Centenara Labs AG (« Centenara ») Le changement de marque positionne l’entreprise pour des initiatives stratégiques destinées à soutenir [...]

EON Medical & Wellness: Transforming Healthcare for the Hispanic Community Through Cutting-Edge Telehealth

19/09/2024 - 21:32

Revolutionizing Healthcare Access with Culturally Focused, Language-Accessible Care TAMPA, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) -- EON Medical + Wellness , a pioneering force in healthcare, is making waves in the [...]

Novo Nordisk A/S: Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function

19/09/2024 - 21:10

Wegovy ® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function Wegovy ® (semaglutide 2.4 mg) is the first obesity medication to [...]

Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments

19/09/2024 - 20:20

Gimoti remains the sole proprietary FDA approved treatment for symptoms of diabetic gastroparesis SOLANA BEACH, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical [...]

Bright Green Corporation Provides an Update, Reinforces Commitment to Shareholders, and Focuses on Growth and Strategic Partnerships

19/09/2024 - 19:56

GRANTS, NEW MEXICO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or the “Company”), today announced that trading of its shares have been suspended from the Nasdaq Stock [...]

Business Collaborative for Brain Health Partners with HERO to Launch the Brain Health Best Practice Score for Employers

19/09/2024 - 19:30

New educational tool will help companies assess how well their health and well-being programs support their workforce’s brain health, a critical factor in employees’ overall health, performance and productivity NEW YORK [...]

Oculis and EURETINA Announce the Winner of the Inaugural Ramin Tadayoni Award

19/09/2024 - 19:00

ZUG, Switzerland, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, in collaboration with EURETINA [...]